Acadia Pharmaceuticals Inc. (ACAD) has been the model of inconsistency and unpredictability over the last year. ACAD is currently trading right in the middle of its 52-week range, between $16.64 and ...
Our second entry in the Biotech Stocks That Could Double in 2016 series, Acadia Pharmaceuticals (ACAD) finds itself with a very similar outlook to Celldex Therapeutics (CLDX), our first entry. However ...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Acadia Pharmaceuticals Inc (NASD: ACAD), where a total of 12,915 contracts have traded so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results